Literature DB >> 11235989

Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.

Q Meng1, J Xu, I D Goldberg, E M Rosen, R A Greenwald, S Fan.   

Abstract

Chemically modified tetracyclines (CMTs) are promising anti-cancer agents. In this study, we found that CMT-3 and CMT-8 showed dose-dependent cytotoxicities in MDA-MB-468 human breast cancer cells. Moreover, both CMT-3 and CMT-8 significantly inhibited in vitro cell migration and invasion at non-cytotoxic concentrations. Anti-invasion and migration potentials of the CMTs were associated with an increased expression of E-cadherin/catenins (alpha, beta and gamma-catenin) and tumor suppressor BRCA1. In addition, CMT-3 and CMT-8 abolished or reduced spontaneous and HGF/SF-induced cell invasion and migration in U-373 MG human glioblastoma cells. Our current finding is the first demonstration that CMT-3 and CMT-8 can activate the function of invasion suppressor molecules associated with the suppression of breast cancer cell invasion and migration. Thus, clinical application of CMTs may provide potential benefit for suppression of breast cancer growth, invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11235989     DOI: 10.1023/a:1006732424102

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  56 in total

1.  CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer.

Authors:  M G Selzer; B Zhu; N L Block; B L Lokeshwar
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

2.  Effects of tetracyclines on angiogenesis in vitro.

Authors:  R S Fife; G W Sledge; S Sissons; B Zerler
Journal:  Cancer Lett       Date:  2000-05-29       Impact factor: 8.679

3.  Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro.

Authors:  Y Cakir; K A Hahn
Journal:  In Vivo       Date:  1999 Jul-Aug       Impact factor: 2.155

Review 4.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

5.  Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.

Authors:  P G Rio; D Pernin; J O Bay; E Albuisson; F Kwiatkowski; M De Latour; D J Bernard-Gallon; Y J Bignon
Journal:  Int J Oncol       Date:  1998-10       Impact factor: 5.650

6.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

Review 7.  Met-HGF/SF: tumorigenesis, invasion and metastasis.

Authors:  G F Vande Woude; M Jeffers; J Cortner; G Alvord; I Tsarfaty; J Resau
Journal:  Ciba Found Symp       Date:  1997

8.  Effects of doxycycline on human prostate cancer cells in vitro.

Authors:  R S Fife; G W Sledge; B J Roth; C Proctor
Journal:  Cancer Lett       Date:  1998-05-15       Impact factor: 8.679

Review 9.  Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

Authors:  B R Rifkin; A T Vernillo; L M Golub
Journal:  J Periodontol       Date:  1993-08       Impact factor: 6.993

10.  The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics.

Authors:  A M Kroon; B H Dontje; M Holtrop; C Van den Bogert
Journal:  Cancer Lett       Date:  1984-11       Impact factor: 8.679

View more
  9 in total

1.  TWIST is expressed in human gliomas and promotes invasion.

Authors:  Maria C Elias; Kathleen R Tozer; John R Silber; Svetlana Mikheeva; Mei Deng; Richard S Morrison; Thomas C Manning; Daniel L Silbergeld; Carlotta A Glackin; Thomas A Reh; Robert C Rostomily
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

2.  Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices.

Authors:  Christopher Franco; Bernard Ho; Diane Mulholland; Guangpei Hou; Muzharul Islam; Katey Donaldson; Michelle Patricia Bendeck
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

3.  A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.

Authors:  Muzharul M Islam; Christopher D Franco; David W Courtman; Michelle P Bendeck
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

4.  Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair.

Authors:  Balakrishnan Sivaraman; Anand Ramamurthi
Journal:  Acta Biomater       Date:  2013-01-29       Impact factor: 8.947

5.  Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.

Authors:  Terumasa Nakagawa; Yutaka Kakizoe; Yasunobu Iwata; Yoshikazu Miyasato; Teruhiko Mizumoto; Masataka Adachi; Yuichiro Izumi; Takashige Kuwabara; Naoki Suenaga; Yuki Narita; Hirofumi Jono; Hideyuki Saito; Kenichiro Kitamura; Masashi Mukoyama
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

6.  Two Antibiotics, Ampicillin and Tetracycline, Exert Different Effects in HT-29 Colorectal Adenocarcinoma Cells in Terms of Cell Viability and Migration Capacity.

Authors:  Emil-Florin Hut; Matilda Radulescu; Nicolae Pilut; Ioana Macasoi; Delia Berceanu; Dorina Coricovac; Iulia Pinzaru; Octavian Cretu; Cristina Dehelean
Journal:  Curr Oncol       Date:  2021-07-04       Impact factor: 3.677

7.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

8.  Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells.

Authors:  Michel Desjarlais; Jonathan Pratt; Amine Lounis; Catherine Mounier; Khadidja Haidara; Borhane Annabi
Journal:  Gene Regul Syst Bio       Date:  2014-03-04

9.  Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.

Authors:  Parvin Ataie-Kachoie; David L Morris; Mohammad H Pourgholami
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.